As of 2025-10-29, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 15.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.25 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 187.8%.
The range of the Relative Valuation is 8.93 - 21.32 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 22.2x | 19.7x |
| Forward P/E multiples | 18.7x - 28.4x | 23.6x |
| Fair Price | 8.93 - 21.32 | 15.11 |
| Upside | 70.1% - 306.0% | 187.8% |
| Date | P/E |
| 2025-10-28 | 5.44 |
| 2025-10-27 | 5.48 |
| 2025-10-24 | 5.44 |
| 2025-10-23 | 5.24 |
| 2025-10-22 | 5.44 |
| 2025-10-21 | 5.37 |
| 2025-10-20 | 5.67 |
| 2025-10-17 | 5.69 |
| 2025-10-16 | 5.62 |
| 2025-10-15 | 5.72 |
| 2025-10-14 | 5.52 |
| 2025-10-13 | 5.50 |
| 2025-10-10 | 5.32 |
| 2025-10-09 | 5.42 |
| 2025-10-08 | 5.44 |
| 2025-10-07 | 5.39 |
| 2025-10-06 | 5.23 |
| 2025-10-03 | 5.33 |
| 2025-10-02 | 5.43 |
| 2025-10-01 | 5.48 |
| 2025-09-30 | 5.52 |
| 2025-09-29 | 5.25 |
| 2025-09-26 | 5.03 |
| 2025-09-25 | 4.89 |
| 2025-09-24 | 4.91 |
| 2025-09-23 | 4.90 |
| 2025-09-22 | 4.64 |
| 2025-09-19 | 4.60 |
| 2025-09-18 | 4.70 |
| 2025-09-17 | 4.51 |
| 2025-09-16 | 4.70 |
| 2025-09-15 | 4.82 |
| 2025-09-12 | 4.65 |
| 2025-09-11 | 4.68 |
| 2025-09-10 | 4.72 |
| 2025-09-09 | 4.90 |
| 2025-09-08 | 4.74 |
| 2025-09-05 | 5.23 |
| 2025-09-04 | 5.31 |
| 2025-09-03 | 5.33 |
| 2025-09-02 | 5.31 |
| 2025-08-29 | 5.24 |
| 2025-08-28 | 5.17 |
| 2025-08-27 | 5.30 |
| 2025-08-26 | 5.39 |
| 2025-08-25 | 5.19 |
| 2025-08-22 | 5.46 |
| 2025-08-21 | 5.43 |
| 2025-08-20 | 5.31 |
| 2025-08-19 | 5.29 |